Ең жақсы Бір бөлімнің МРТ сынағы дәрігерлері - ЖОҒ-492 дәрігерлер

Контент Bookimed редакциялық саясатына сәйкес келеді және оның сапасын тексерген

Фахад Мавлюд

Tural Pashayev

  • 4.7 Керемет 16 пікірлер
  • 10 жылдар тәжірибе
  • Әзербайжан, Бакі, Liv Bona Dea Hospital Baku
Сүт безі қатерлі ісігіндегі операция
4 900 $ - 7 000 $
Омыртқа аралық жарықты алып тастау
7 500 $ - 9 900 $
ТУИ (трансуретралды инцизия) простата
5 500 $ - 7 000 $
Ақпарат

Tahsin Ozatli

  • 4.4 Жақсы 16 пікірлер
  • 2015 жылдар тәжірибе
  • Түркия, Істанбұл, Istinye University Liv Hospital Bahcesehir
  • Oncologist
Радиожиілікті абляция
6 000 $ - 6 000 $
Лобэктомия (өкпенің бөлігін алып тастау)
9 849 $ - 13 015 $
Ми ісігін алып тастау
14 000 $ - 22 000 $
Ақпарат

Yusuf Acikgoz

  • 4.8 Керемет 5 пікірлер
  • 9 жылдар тәжірибе
  • Түркия, Анқара, Lokman Hekim University Ankara Hospital
  • Associate Professor Dr. Yusuf AÇIKGÖZ
    Specialization: Medical Oncology

    Education:

    • 2004-2011: İnönü University Faculty of Medicine
    • 2011-2016: Ankara Numune Training and Research Hospital, Internal Medicine
    • 2017-2022: Health Sciences University, Medical Oncology

    Professional Experience:

    • 2016-2017: Bingöl City Hospital, Internal Medicine
    • 2021-2022: Health Sciences University, Medical Oncology
    • 2022-2023: Kastamonu Education and Research Hospital, Medical Oncology
    • 2023-2024: Ohio State University, Medical Oncology
    • 2024-Present: Lokman Hekim University, Medical Oncology, Ankara Hospital

    Clinical Trials, Courses, Certifications:

    Clinical Trials:

    • 2017-2021: Phase III, CheckMate-649 Study (Assistant Investigator)
    • 2022-Present: Phase III, Fortitude-101 Study (Assistant Investigator)

    Courses:

    • 2018: Medicres Basic and Advanced Biostatistics Training Program (ongoing), Istanbul-Vienna
    • 2019: Immuno-Oncology Education Course, March 1-2, 2019, Vienna, Central European Cooperative Oncology Group (CECOG)
    • 2018: Good Clinical Practice Certification, April 7-8, 2018, Ankara, Health Sciences University
    • 2017: Basic Oncology Training Program, November 25-26, 2017, Adana, Clinical Oncology Society
    • 2016: Basic Ultrasonography Course (10 hours theoretical + 10 hours practical), September 24-25, 2016, Ankara, Turkish Emergency Medicine Association

    Certifications:

    • Ongoing: ECFMG Certification
    • 2024: CITI Responsible Conduct of Research (The Ohio State University)
    • 2024: CITI IACUC-Laboratory Animal Research (The Ohio State University)
    • 2024: CITI Human Subjects Protection (The Ohio State University)
    • 2024: CITI Good Clinical Practice (The Ohio State University)
    • 2023: Occupational English Test (OET)
    • 2019: International English Language Testing System (IELTS), Total Score: 6.5, May 26, 2019, Ankara, British Council
    • 2017: USMLE Step 2 CK Exam; Score: 244, February 7, 2017
    • 2016: USMLE Step 1 Exam; Score: 215, August 25, 2016

    Memberships:

    • American Society of Clinical Oncology (ASCO) - 2022
    • Turkish Society of Medical Oncology - 2020
  • Толығырақ оқу
Дискэктомия
6 345 $ - 6 345 $
Өкпе рагын емдеу үшін операция
10 940 $ - 16 410 $
Сколиозға операция
10 000 $ - 14 500 $
Ақпарат

Ercan Ozden

  • 5 Керемет 1 пікірлер
  • 26 жылдар тәжірибе
  • Түркия, Істанбұл, VM Medical Park Pendik Hospital
  • Dr. Ercan Ozden is a specialist in internal medicine and medical oncology. He earned his medical degree and completed his residency at Istanbul University, Cerrahpaşa Faculty of Medicine. He later received a subspecialty in medical oncology at Kocaeli University Faculty of Medicine from 2016 to 2020.

    Dr. Ozden has worked in medical oncology at Şırnak State Hospital. He has also served as an internal medicine specialist at Bağcılar Private Safa Hospital and Küçükçekmece Batı Bahat Hospital. He has extensive clinical experience in both internal medicine and oncology.

  • Толығырақ оқу
Сабақ жасушаларымен емдеу
5 000 $ - 6 000 $
Мастэктомия
6 500 $ - 8 000 $
Ламинэктомия
7 000 $ - 8 000 $
Ақпарат

Dr Sanchez Yague

  • 4.4 Жақсы 5 пікірлер
  • 26 жылдар тәжірибе
  • Испания, Марбелья, Quirónsalud Marbella
  • In 2007 he joined the Costa del Sol Hospital and left this position when he obtained an international scholarship that would take him back to San Francisco. In 2010 he moved to Japan to complete his training in the submucosal endoscopic dissection technique that he would later on introduce in Andalusia in 2011, thus becoming one of the pioneers in the performance of this technique in Spain. In 2011 he became the first medical professional in the world to use the 15-mm AXIOS stent in pancreatic fluid collection drainage. In 2018 he began to perform gastroenteroanastomosis with luminal apposition stent in patients with pancreatic cancer and bowel obstruction, thus becoming a pioneer in Andalusia to perform such technique.

    He is a coauthor of the reference guides of the European Society of Gastrointestinal Endoscopy on the endoscopic treatment of chronic pancreatitis and non-variceal gastrointestinal haemorrhage.

    Professional Experience

    Over 24 years' experience

    1999 - Degree in Medicine and Surgery. Malaga University, Spain.

    2003 to 2006 - Medical Residency in the Digestive System at the Virgen Macarena Hospital in Seville, Spain.

    2006 - International Scholar at the California Pacific Medical Center in San Francisco, USA.

    2007 – Digestive System Specialist at the Costa del Sol Hospital, Marbella. Spain.

    2008 - California Pacific Medical Center in San Francisco, USA.

    2009 - Top Reviewer Award received from the Gastrointestinal Endoscopy Journal.

    2011 – Pioneer in Spain in the introduction of the submucosal endoscopic dissection technique.

    2011 – First professional in the world to use the AXIOS (15mm) stent for pancreatic fluid collection drainage.

    2016 - Gold Medal of the Andalusian Society for Digestive Disease (SAPD, in its Spanish abbreviation).

    2017 - Fellow of the American College of Gastroenterology (FACG).

    2018 - Pioneer in Andalusia to perform gastroenteroanastomosis with luminal apposition stent to treat bowel obstruction.

    2019 - Fellow of the American Society for Gastrointestinal Endoscopy (FASGE).

     

    The Digestive System Unit of the Quirónsalud Marbella Hospital offers a patient service portfolio that includes all the clinical aspects of gastroenterology, hepatology, biliary duct and pancreatic disease, as well as the diagnostic and treatment techniques used in this speciality such as abdominal ultrasound, endoscopy and other functional tests.

    Our specialists have solid professional backgrounds and the team is highly qualified for the diagnosis and treatment of complex diseases such as conditions related to acidity (gastric ulcers, helicobacter pylori, gastroesophageal reflux disease), enteropathies (Crohn's Disease, ulcerative colitis; coeliac disease...), viral hepatitis, hepatic cirrhosis, pancreatic disease...

    The Digestive System Unit of the Quirónsalud Marbella Hospital is a pioneer in the implementation of a specific check-up programme for digestive disease with special attention to the diagnosis and treatment of colon precancerous lesions.

    Diseases, treatments and techniques:

    • Diagnostic and therapeutic endoscopic ultrasound

    • Endoscopic resection techniques (mucosectomy/submucosal dissection)

    • Submucosal or third-space endoscopy (POEM and variants)

    • Bariatric endoscopy (Apollo Method)

  • Толығырақ оқу
Дәрігерге бару
Бағасы сұрау бойынша
Ақпарат

Peter Schenker

  • 4.7 Керемет 60 пікірлер
  • 18 жылдар тәжірибе
  • Германия, Золинген, Medical Center in Solingen
  • Membership in societies:

    Expert of scientific journals 

    Close co-operation with leading surgeons

    Membership of the German Medical Association 

    Specialities:

    Introduction of new and modern techniques in the field of oncological surgery
    General and visceral surgery

    Minimally invasive surgery

    Gastrointestinal oncology surgery

    Oncological surgery

    Haemorrhoids treatment

    Additional clinical specialisation in minimally invasive and hernia surgery

    Surgery and transplantation of the pancreas

    Work Experience:

    2005: Specialist in the field of surgery

    2008: Appointed Senior Consultant specialising in pancreatic surgery and transplantation

    2010: Coordinator of the Pancreatic Cancer Centre (Oncocert)

    2013: Specialist in visceral surgery

    2014: Managing Senior Physician, additional clinical specialisation in minimally invasive and hernia surgery

    2019: Chief Surgeon of the Colorectal Cancer Centre Bochum (the first certified colorectal cancer centre in Germany and one of the first certified leading colorectal centres in Europe)

    2021: Chief Surgeon of the Department of Surgery at the Academic Hospital Solingen

    Thanks to the professor and his team, the department has been modernised by introducing modern surgical methods of treatment and especially improved methods of post-operative recovery. The Department of Surgery at the Solingen Clinic is now further expanding its focus on minimally invasive surgery in the direction of robotics. The clinic has allocated a huge budget for the purchase of state-of-the-art equipment in order to offer patients a full range of surgical methods for the treatment of benign and malignant diseases of the oesophagus, lungs, stomach, liver, pancreas and intestines according to current guidelines and using the most modern technical equipment.

    Professor Schenker is an active researcher and lecturer. He lectures at medical universities and organises seminars and workshops for colleagues. He cooperates closely with the Cancer Centre, the Pancreatic Cancer Treatment Centre, the Intestinal Cancer Treatment Centre and the Interregional Trauma Centre.

  • Толығырақ оқу
Қуыққа ТУР
8 794 $ - 8 794 $
Ақпарат

Sven Propson

  • 4.7 Керемет 60 пікірлер
  • 19 жылдар тәжірибе
  • Германия, Золинген, Medical Center in Solingen
  • Under his leadership, the hospital is actively expanding its services, including paediatric cardiology and intensive care, and is planning to establish an interdisciplinary center for parents and children on the basis of the Department of Paediatrics.

    Dr. Propson's many years of experience have established him as a leading expert in neonatology and paediatric cardiology in Germany and Europe. His dedication and commitment to the highest level of care for young patients is reflected in his work. Dr. Propson's research and scientific publications demonstrate his in-depth knowledge and commitment to development in paediatrics.

    For many years Dr. Propson worked as a leading physician in the Department of Paediatrics and Adolescent Medicine at the Leverkusen Clinic in Leverkusen, Germany, where he was also responsible for managing the paediatric intensive care unit. In addition to his primary work, Dr. Propson devotes a great deal of time to continuing education to ensure that his patients receive the most up-to-date treatments in his department.

    His unique professional qualities and qualifications set him apart from other physicians. Dr. Propson's patients can rest assured that they are in good hands at the Department of Paediatrics and Adolescent Medicine at the Academic Hospital Solingen.

    Membership in societies:

    German Association of Physicians

    Expert of scientific journals

    Specialisations:

    Emergency medicine

    Intensive care

    Paediatric cardiology

    Neonatology

    Work Experience:

    2006: Graduation from the Faculty of Medicine

    2006 - 2011: Specialization as a specialist in paediatrics and adolescent medicine.

    2011 - 2023: Lead physician in the Department of Paediatrics and Adolescent Medicine at the Leverkusen Clinic.

    2023: Chief physician in the Department of Paediatrics at the Academic Hospital Solingen.

     

  • Толығырақ оқу
Қуыққа ТУР
8 794 $ - 8 794 $
Ақпарат

Associate Professor Burak Orhan Boran

  • 5 Керемет 3 пікірлер
  • 23 жылдар тәжірибе
  • Түркия, Істанбұл, Medipol Acibadem District Hospital
  • EDUCATION:

    • Turhan and Mediha Tansel Primary School (1979–1984)
    • Kültür College (1984–1988)
    • Semiha Şakir High School (1988–1991)
    • Marmara University Faculty of Medicine (1991–1997)
    • Marmara University Faculty of Medicine, Neurosurgery Department, Specialist Training (1997–2002)
    • Title of Associate Professor in Neurosurgery (May 31, 2021)

    ADDITIONAL TRAINING:

    • "Visiting Physician," University of Southern California, Department of Neurosurgery (1998)
    • "Microsurgery Training," GATA (Gülhane Military Medical Academy), Ankara Education and Research Hospital (2003)

    PROFESSIONAL EXPERIENCE:

    • Gülhane Military Medical Academy Haydarpaşa Training and Research Hospital (2002–2003)
    • Dr. Lütfi Kırdar Kartal Training and Research Hospital (2003–2005)
    • Private Avicenna Ataşehir Hospital (2005–2012)
    • Private 29 Mayıs Hospital (2012–2013)
    • Maltepe State Hospital (2013–2018)
    • Kartal Dr. Lütfi Kırdar City Hospital (2018–2020)
    • Private Academic Hospital (2020–2022)
    • Hisar Intercontinental Hospital (2022–2024)
    • Private Medipol Acıbadem Regional Hospital (2024–Present)

    ADMINISTRATIVE AND ACADEMIC ROLES:

    • Board Member, Neurosurgical Society (2006–2009)
    • Head of the Emergency Department, Maltepe State Hospital (2014–2016)
    • Deputy Chief Physician, Private Academic Hospital (2020–2021)
    • Advisory Board Member, Beykent University Faculty of Medicine (2018–2024)
    • Faculty Member, Galata University Faculty of Health Sciences (2022–2024)
    • Director, Continuous Education Center, Galata University (2022–2024)

     

     

     

  • Толығырақ оқу
Дәрігерге бару
Бағасы сұрау бойынша
Ақпарат

Sebastian Keil

  • 4.7 Керемет 60 пікірлер
  • 21 жылдар тәжірибе
  • Германия, Золинген, Medical Center in Solingen
  • Professor Dr. Sebastian Keil is a recognized expert in the field of interventional radiology and is considered one of the leading specialists in Germany and in Europe. He is a professional in his field, thanks to whom many patients receive timely diagnosis and effective treatment. Professor Keil and his team of specialists have extensive knowledge of anatomy, physiology and pathology, as well as an understanding of the various methods of performing and interpreting radiological examinations.
  • Толығырақ оқу
Қуыққа ТУР
8 794 $ - 8 794 $
Ақпарат

Dr Murat Ayhan

  • 5 Керемет 7 пікірлер
  • 35 жылдар тәжірибе
  • Түркия, Істанбұл, Liv Hospital Vadistanbul
  • Areas of Interests

    • Breast cancer
    • Lung cancer
    • Colorectal cancers
    • Gynecological and urogenital cancers
    • Molecular Oncology

    Education:

    • Kızıltepe Anatolian High School 2001
    • Dicle University Faculty of Medicine 2007
    • Istanbul Medeniyet University Göztepe Training and Research Hospital 2014
    • Kartal City Hospital 2021
    • Associate Professor of Medical Oncology 2023

    Experience:

    • Liv Hospital Ulus
    • Adıyaman University Training and Research Hospital
    • Istanbul Umraniye Training and Research Hospital
    • Istanbul Umraniye Training and Research Hospital

    Research:

    • Phase II, Randomized, Open-Label, Multicenter Study to Comparatively Evaluate the Efficacy and Safety of GDC-9545 and Physician-Preferred Endocrine Monotherapy in Previously Treated, Estrogen Receptor Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer Patients, Other ( International), Dr. Murat Ayhan
    • Phase III, Randomized, Evaluating the Efficacy and Safety of Palbociclib and Fulvestrant with Gdc-0077 Compared with Placebo in Patients with Pik3ca-Mutant, Hormone Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer. Double Blind, Placebo Controlled Study, Other (International), Dr. Murat Ayhan
    • Randomized, Multicenter, Phase Ib/III Study Evaluating the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Atezolizumab Compared to Intravenous Atezolizumab in Patients with Previously Treated Locally Advanced or Metastatic Non-Small Cell Lung Cancer, Other (International) Dr. Murat Ayhan
    • Randomized, Controlled, Multicenter, Open-Label Study Including Observation Follow-Up for PSMA-PET-Negative Patients, Investigating the Efficacy and Safety of Addition of Apalutamide to Radiotherapy and LHRH Agonist in PSMA-PET-Positive High-Risk Hormone-Sensitive Prostate Cancer Patients, Other (International) Dr. Murat Ayhan
    • Biomarker Study to Identify Patients with Advanced Stage Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations-42756493BLC0002, Other (International), Dr. Murat Ayhan
    • Publications:
    • Ayhan M, Turan N, Köstek O, et all. Does the efficacy of regorafenib differ in chemotherapy refractory metastatic colorectal cancer patients who had mucinous pathology compared to those who had non-mucinous pathology? Curr Probl Cancer. 2021 Jun;45(3):100670. doi: 10.1016/j.currproblcancer.2020.100670.
    • Ayhan M, Odabas H, Turan N, et all. Factors affecting the mortality rate of patients with cancer hospitalized with COVID-19: a single center's experience. J Chemother. 2021 Nov;33(7):499-508. doi: 10.1080/1120009X.2021.1923153.
    • Ayhan M, Laçin Ş, Özyükseler DT, et all. Does systemic anti-tumor therapy increase COVID-19 risk in patients with cancer? J Oncol Pharm Pract. 2021 Sep;27(6):1461-1467. doi: 10.1177/10781552211015762.
    • Ayhan M, Abamor E, Coban Kokten S, et al. Value of FDG PET/CT in Predicting Pathologic Complete Response After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer. EJMI 2022;6(2):165–175.
    • Ayhan M, Terzioglu K. Experience With Rapid Drug Desensitization With Chemotherapeutics; A SingleCentre Retrospective Study. EJMI 2021;5(3):380–387.
    • Doğan A, AYHAN M. Survival analysis of patients with triple-negative breast cancer: a single-center experience. Journal of Oncological Sciences, 8(2), 94-99., Doi: 10.37047/jos.2022-89749
    • Terzioğlu K, Ayhan M. Comparative Assessment of Platinum Salts and Taxane Group Hypersensitivity Reactions, The Role of Skin Tests in Diagnosis? J Oncol Pharm Pract. 2021 Nov 30:10781552211050084. doi: 10.1177/10781552211050084.
    • Tacar SY, Selcukbiricik F, Yilmaz M, Erturk K, Murat Sarici A, Gulturk I, Ayhan M, Tural D. Nivolumab for metastatic uveal melanoma: a multicenter, retrospective study. Melanoma Res. 2021 Oct 1;31(5):449-455. doi: 10.1097/CMR.0000000000000744.
    • Özyurt E, Özçelik S, Sürmeli H, Çelik M, Ayhan M, Özçelik M. Side effects of immune-checkpoint inhibitors: Can multiple side effects be seen in a patient? J Oncol Pharm Pract. 2022 Mar;28(2):462-465. doi: 10.1177/10781552211038136.
    • Dülgar Ö, Öven BB, Atcı MM, Arıkan R, Ay S, Ayhan M, Selvi O, Ozyukseler DT, Bayram E, Özcan E, Yasin Aİ, Gümüş M. Is the benefit of using adjuvant capecitabine in patients with residual triple-negative breast cancer related to pathological response to neoadjuvant chemotherapy? Expert Rev Anticancer Ther. 2022 Jul;22(7):773-780. doi: 10.1080/14737140.2022.2076670.
    • Hizal M, Bilgin B, Paksoy N, Ayhan M, et all. The real-life efficacy and safety of osimertinib in pretreated advanced non-small cell lung cancer patients with T790M mutation: a Turkish Oncology Group Study. J Cancer Res Clin Oncol. 2022 Jun;148(6):1501-1508. doi: 10.1007/s00432-021-03748-7.
    • Volume I, Kucukarda A, Atcı MM, Ayhan M, et all. Efficacy and safety of trastuzumab emtansine in older patients with HER2-positive advanced breast cancer: a real-world study. Tumori. 2022 Feb;108(1):19-25. doi: 10.1177/03008916211037739.
    • Dogan I, Ayhan M, Gurbuz M, et all. The frequency and prognostic significance of ABO/Rh blood groups in male breast cancer patients: A multicenter study. Medicine (Baltimore). 2022 Sep 2;101(35):e30147. doi: 10.1097/MD.0000000000030147.
    • Ozcelik M, Oyman A, Cil I, Duzgun O, Ozkan OF, Ayhan M. Cytoreductive Surgery versus Systemic Chemotherapy alone in Isolated Peritoneal Carcinomatosis of Colorectal Origin. J Coll Physicians Surg Pak. 2021 Nov;31(11):1308-1313. doi: 10.29271/jcpsp.2021.11.1308.
    • Başoğlu T, Sakin A, Erol C, Ayhan M, et all. Real life experienceof patients with locally advanced gastric and gastroesophageal junction adenocarcinoma treated with neoadjuvant chemotherapy: a Turkish oncology group study. J Chemother. 2022 May 17:1-8. doi: 10.1080/1120009X.2022.2073159.
    • Özdemir Ö, Zengel B, Yildiz Y, Ayhan M, et all. The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study. Anticancer Drugs. 2022 Aug 1;33(7):663-670. doi: 10.1097/CAD.0000000000001310.
    • Hizal M, Bilgin B, Paksoy N, Ayhan M, et all. The percentage of ALK-positive cells and the efficacy of first-line alectinib in advanced non-small cell lung cancer: is it a novel factor for stratification? (Turkish Oncology Group Study). J Cancer Res Clin Oncol. 2022 Sep 1. doi: 10.1007/s00432-022-04252-2.
    • Hizal M, Bilgin B, Paksoy N, Ayhan M, et all. Real-world data on efficacy and safety of first-line alectinib treatment in advanced-stage, ALK-positive non-small-cell lung cancer patients: a Turkish Oncology Group study. Future Oncol. 2022 Jul;18(23):2573-2582. doi: 10.2217/fon-2022-0083.
    • Topcu A, Atci MM, Secmeler S, Besiroglu M, Ayhan M, Ozkan M, Bozkurt O, Urakci Z, Ay S, Geredeli C, Yasin AI, Turk HM. Efficacy of trastuzumab and potential risk factors on survival in patients with HER2-positive metastatic gastric cancer. Future Oncol. 2021 Nov;17(31):4157-4169. doi: 10.2217/fon-2021-0398.
    • Bilgin B, Sendur MAN, Yucel S, Ayhan M, et all. Real-life comparison of the afatinib and first-generation tyrosine kinase inhibitors in nonsmall cell lung cancer harboring EGFR exon 19 deletion: a Turk Oncology Group (TOG) study. J Cancer Res Clin Oncol. 2021 Jul;147(7):2145-2152. doi: 10.1007/s00432-020-03501-6.
    • Atci MM, Akagunduz B, Demir M, Arikan R, Ay S, Ozer M, Ayhan M, Cil I, Demir N, Ozyurt N, Karakaya G, Cevik GT, Onder AH, Selvi O, Sakin A. The impact of adjuvant oxaliplatin and tumor sidedness on the overall survival of stage IIB colon cancer patients: a multicentre study. J Chemother. 2023 Feb;35(1):19-28. doi: 10.1080/1120009X.2022.2040770.
    • Tataroglu Ozyukseler D, Ay S, Turan M, Alkan G, Ayhan M, Surmeli H, et al. The Systemic Inflammation Response Index as a Prognostic Marker in Advanced Pancreatic Cancer. EJMI 2022;6(3):367–373.
    • Yıldız F, Ayhan M, Demir H, et all. Comparing the efficacy of cabazitaxel in secondline and third-Line treatment of metastatic castration-resistant prostate cancer: a multi-center experience from Turkey. International Journal of Contemporary Medical Research, 7(9), 112-116.,Doi: 10.21276/ijcmr.2020.7.9.30
    • Terzioğlu K, Ayhan M. Distribution of allergens detected on patch tests of patients with allergic contact dermatitis and investigation of their atopic background. Annals of Medical Research, 29(5), 422-426., doi: 10.5455/annalsmedres.2021.07.490
    • Arikan R, Atci MM, Ay S, Ayhan M, et all Prognostic significance of mucinous histology in left sided metastatic colorectal cancers with wild type RAS and evaluation of backbone chemotherapy regimens. Oncol Lett. 2023 Apr 5;25(5):208. doi: 10.3892/ol.2023.13795.
    • Almuradova E, Yalcin S, Arıkan R, Ayhan M, Demir H, Cevik GT, Karaca M, Petekkaya I, Karabulut B. Survival of Patients With Metastatic Rectum Cancer Who Underwent Metastasectomy Following Conversion Chemotherapy Sans Pelvic Radiotherapy: A Turkish Oncology Group Study. Cureus 2023 May 17;15(5):e39119. doi: 10.7759/cureus.39119.
    • Topcu A, Besiroglu M, Atci MM, Ayhan M, et all. Second-line Therapy after Trastuzumab Failure in HER2-Positive Metastatic Gastric Cancer: A Real-life Data. EJMI 2023;7(2):153–161. DOI: 10.14744/ejmi.2023.22720
    • Book Writing:
    • Drug interactions and side effects of targeted agents, Section name: (Small molecule tyrosine kinase inhibitors; ROS-1 targeted therapies (Crizotinib, Seritinib)) (2021)., AYHAN MURAT, Turkish Clinics Journal of Medical Sciences, Editor: Mehmet Aliustaoglu, Publishing number:1, Number of Pages 92, ISBN:978-625-401- 466-6, Turkish
    • Approach to gastrointestinal stromal tumors and neuroendocrine tumors, Department name: (Medical approach in primary non-gastrointestinal neuroendocrine tumors) (2020)., AYHAN MURAT, Akademisyen Yayınevi, Editor: Anılır Ender, Number of editions: 1, Number of Pages 382, ISBN: 9786052585719, Turkish
    • Internal medicine emergencies, Department name: (Oncological emergencies) (2022)., YILDIRIM SEDAT, AYHAN MURAT, Efe Academic Publishing, Editor: Serdar Olt, Number of editions: 1, Number of Pages 232, ISBN: 978-625-8324-66- 2, Turkish
    • Physicians' chemotherapy cancer drug manual 2020, Section name: (Common chemotherapy regimens in clinical practice) (2022)., SÜMBÜL AHMET TANER, ALKAN ALI, AKSOY ASUDE, AYHAN MURAT, et all, Türkiye Klinikleri Journal of Medical Sciences, Editor: EDWAR CHU, VINCENT T. DEVITA, SAADDETIN KILIÇKAP, CEMIL BILIR, SELÇUK SEBER, Number of editions: 1, Number of pages 772, ISBN: 978-625-401-290- 7, Turkish (Book Translation)

     

  • Толығырақ оқу
Блуждаушы нервті ынталандыру
22 000 $ - 22 000 $
Химиотерапия
3 000 $ - 3 500 $
Ақпарат

Emre Merdan Fayda

  • 5 Керемет 7 пікірлер
  • 45 жылдар тәжірибе
  • Түркия, Істанбұл, Liv Hospital Vadistanbul
  • Areas of Interests

    • MR Linac
    • Three Dimensional Brachytherapy
    • Four Dimensional (4D) Radiotherapy
    • Stereotactic RT & IMRT
    • Breast Cancer, Gynecological Cancers
    • Head – Neck Cancers
    • Urological Tumors, Gastrointestinal Cancers
    • Lung Cancer
    • Central Nervous System Tumors & Metastases
    • Skin Cancers
    • Soft Tissue Tumors

    Education:

    • Istinye University Medical Faculty, Professor Doctor (2017 – Continued)
    • Istine University Medical Faculty Associate Professor Doctor (2016 – 2017)
    • Liv Hospital Radiation Medicine Center, Tbilisi, Georgia, Radiation Oncology Consulting Docor (2016 – 2019)
    • Liv Hospital, Radiation Oncology (2015 – Continued)
    • Istanbul University Oncology Institution, Associate Professor (2012 – 2015)
    • Stereotactic Radiotherapy, Thoracic Oncology, University of North Carolina, NC, USA (2010 – 2011)
    • Kocaeli University Radiation Oncology Department, Associate Professor Assistant (2006 – 2009)
    • GATA Radiation Oncology Department, Specialist Doctor, Reserve Officer (2004 – 2005)
    • Istanbul University, Medical Faculty, Dr.R.A. (1999 – 2004)
    • Istanbul University, Medical Faculty, Under-Graduate (1993 – 1999)
       

    Experience:

    • Istinye University Medical Faculty
    • Liv Hospital Ulus
    • Istanbul University Oncology Institution
    • University of North Carolina, NC, USA
    • Kocaeli University Medical Faculty
    • Istanbul University, Medical Faculty
  • Толығырақ оқу
Блуждаушы нервті ынталандыру
22 000 $ - 22 000 $
Химиотерапия
3 000 $ - 3 500 $
Ақпарат

Hatice Balaban

  • 5 Керемет 7 пікірлер
  • 30 жылдар тәжірибе
  • Түркия, Істанбұл, Liv Hospital Vadistanbul
  • Areas of Interests

    • Parkinson's disease
    • Essential tremor
    • Dystonia and other involuntary movements
    • Balance and gait disorders
    • Alzheimer's Disease and other dementias
    • Spasticity
    • Brain vascular diseases
    • Migraine and other headaches
    • Epilepsy
    • Botulinum toxin application in dystonia
    • Botulinum toxin application in spasticity
    • Botulinum toxin application in migraine headache

    Education:

    • Bachelor of Medicine Ankara University 1988-1994
    • Medical Specialization Neurology Ankara University Faculty of Medicine 1995-2000
    • Associate Professorship Neurology Cumhuriyet University Faculty of Medicine 09/10/ 2013

    Experience:

    • General Practitioner Ankara Yenimahalle Health Center 1994-1995
    • Research Assistant Ankara University Faculty of Medicine, Department of Neurology 1995-2000
    • Specialist Dr. Sevgi Milennium Hospital 2000-2001
    • Specialist Dr. Deda Brain Spinal Cord Diseases Center 2001-2002
    • Specialist Dr. Pamukkale University Faculty of Medicine 2002-2003
    • Specialist Dr Sivas Numune Hospital 2003-2007
    • Specialist Dr. Private Sivas Anadolu Hospital 2007-2009
    • Asst. Assoc. Dr. Department of Neurology, Cumhuriyet University Faculty of Medicine, Sivas 2009-2013
    • Assoc Prof Dr Neurology Department AD, Cumhuriyet University Faculty of Medicine, Sivas October 2013- October 2016
    • Assoc Prof Dr Medicana Sivas Hospital- March 2017-June 2020
    • Assoc Prof Dr Medicana International Ankara Hospital August 2020-
  • Толығырақ оқу
Блуждаушы нервті ынталандыру
22 000 $ - 22 000 $
Химиотерапия
3 000 $ - 3 500 $
Ақпарат

Omer Burcak Binicier

  • Жаңа
  • 13 жылдар тәжірибе
  • Түркия, Ізмір, Medicalpoint International Hospital
  • Dr. Omer Burcak Binicier is a gastroenterology specialist with strong medical training. He earned his medical degree at Ege University. He completed his internal medicine and gastroenterology specialization at Dokuz Eylül University Faculty of Medicine. Dr. Binicier has over ten years of clinical experience. He has held key positions at SBÜ Tepecik Training and Research Hospital and İzmir Bayraklı City Hospital. He also gained international experience at Korea University.

    Dr. Binicier diagnoses and treats a wide range of gastrointestinal diseases. His expertise includes early colon and stomach cancers, inflammatory bowel diseases, liver and pancreatic disorders, and digestive system cancers. He uses advanced endoscopic techniques such as EMR, ESD, ERCP, and endoscopic ultrasound. He is also skilled in minimally invasive obesity treatments. His clinical skills are built on years of hands-on work in top medical centers.

  • Толығырақ оқу
Дәрігерге бару
Бағасы сұрау бойынша
Ақпарат

Mert Filibeli

  • Жаңа
  • 16 жылдар тәжірибе
  • Түркия, Ізмір, Medicalpoint International Hospital
  • Dr. Mert Filibeli is a specialist in Orthopedics and Traumatology. He completed his residency at the University of Health Sciences Tepecik Teaching and Research Hospital in 2017. He currently works as a surgeon at Medicalpark Hospital and İzmir University of Economics. He has also worked at Buca Seyfi Demirsoy Teaching and Research Hospital and Dr. Behçet Uz Pediatric Diseases and Surgery Teaching and Research Hospital.

    Dr. Filibeli is a member of the Turkish Society of Orthopaedics and Traumatology since 2012. He has also been a member of the Turkish Orthopedics Education Council since 2017. He is fluent in English (YDS 87.5) and German (Deutsches Sprachdiplom C-2).

  • Толығырақ оқу
Дәрігерге бару
Бағасы сұрау бойынша
Ақпарат

Itir Sirinoglu Temiz

  • 5 Керемет 7 пікірлер
  • 35 жылдар тәжірибе
  • Түркия, Істанбұл, Liv Hospital Vadistanbul
  • Dr. Itir Sirinoglu Temiz is a Professor of Hematology. She specializes in lymphoma, acute and chronic leukemias, multiple myeloma, thrombocytopenias, thrombosis, anemia, and bone marrow failure. She graduated with honors from Istanbul University Cerrahpaşa Faculty of Medicine. She completed her hematology training at Dr. Abdurrahman Yurtarslan Oncology Education and Research Hospital.

    Dr. Sirinoglu Temiz has held key academic and administrative positions. She served as Head of Internal Medicine at IAU Faculty of Medicine. She was also Education and Administrative Manager at SBÜ Bakırköy Dr. Sadi Konuk EAH Hematology Clinic. She has broad experience in adult hematology, stem cell transplantation, and therapeutic apheresis. She currently practices at Liv Hospital.

  • Толығырақ оқу
Блуждаушы нервті ынталандыру
22 000 $ - 22 000 $
Химиотерапия
3 000 $ - 3 500 $
Ақпарат

Burcin Kececi

  • Жаңа
  • 26 жылдар тәжірибе
  • Түркия, Ізмір, Medicalpoint International Hospital
  • Dr. Burcin Kececi is a specialist in orthopedics and traumatology. He focuses on pediatric orthopedics, bone metastases, bone and soft tissue tumors, and orthopedic oncology. He performs advanced surgeries on the knee, hip, ankle, elbow, hand, and shoulder. His skills also include prosthesis replacements, limb lengthening, tendon transfers, and trauma surgery.

    He received additional training in France in knee, hip, and sports injuries. He also trained in minimally invasive hip surgery. Dr. Kececi has worked at Ege University and İzmir Private Hospital. He currently practices at Medical Point İzmir Hospital. He is a member of national and international orthopedic and oncology societies, including ISOLS, SICOT, and EMSOS. He has also served on the board of TOTBİD.

  • Толығырақ оқу
Дәрігерге бару
Бағасы сұрау бойынша
Ақпарат

Baha Zengel

  • Жаңа
  • 11 жылдар тәжірибе
  • Түркия, Ізмір, Medicalpoint International Hospital
  • Dr. Baha Zengel is a general surgeon with expertise in breast, gallbladder, thyroid diseases, and hernia repairs. He graduated from Ege University Faculty of Medicine in 1990. In 2004, he earned a doctorate in Basic Oncology from Dokuz Eylül University. He became an Associate Professor of General Surgery in 2014 through the Inter-University Board.

    Dr. Zengel is skilled in advanced surgical procedures. His experience includes skin and breast-conserving mastectomy, oncoplastic breast surgery, laparoscopic cholecystectomy, sentinel lymph node biopsy, and ROLL/SNOLL techniques. He has held important positions at Izmir Bozyaka Training and Research Hospital, including Education Officer.

    He is a member of several professional associations. He serves on the Board of Directors of the Aegean Region Surgery Association and is a founding board member of the Basic Oncology Association.

  • Толығырақ оқу
Дәрігерге бару
Бағасы сұрау бойынша
Ақпарат

Ela Simay Zengin

  • Жаңа
  • 4 жылдар тәжірибе
  • Түркия, Ізмір, Medicalpoint International Hospital
  • Dr. Ela Simay Zengin is a neurologist. She completed her medical training at Dokuz Eylül University, Başkent University, and Acıbadem University. She has worked at Bitlis Tatvan, Sirnak, and Cizre State Hospitals.

    Dr. Zengin treats Alzheimer’s disease, epilepsy, migraines, multiple sclerosis, Parkinson’s disease, and stroke. She uses advanced treatments, including apomorphine pump therapy, botulinum toxin injections, and migraine vaccines.

    She is a member of the Turkish Neurology Association, American Academy of Neurology, European Academy of Neurology, and International Parkinson and Movement Disorder Society.

  • Толығырақ оқу
Дәрігерге бару
Бағасы сұрау бойынша
Ақпарат

Binnursimsek

  • 5 Керемет 7 пікірлер
  • 35 жылдар тәжірибе
  • Түркия, Істанбұл, Liv Hospital Vadistanbul
  • Dr. Binnur Simsek is a gastroenterology specialist. She has experience in liver cirrhosis, portal hypertension, hepatocellular carcinoma, liver transplantation, and viral hepatitis (B, C, Delta). She also treats alcoholic and non-alcoholic fatty liver disease, peptic ulcers, gastrointestinal bleeding, and inflammatory bowel diseases such as ulcerative colitis and Crohn’s colitis.

    She completed her medical and gastroenterology training at Istanbul University Faculty of Medicine. Dr. Simsek has worked at Istanbul University, Sanlıurfa Education and Research Hospital, Liv Hospital, and Istinye University. She is a member of the Turkish Association for the Study of the Liver and the Turkish Society of Gastroenterology.

  • Толығырақ оқу
Блуждаушы нервті ынталандыру
22 000 $ - 22 000 $
Химиотерапия
3 000 $ - 3 500 $
Ақпарат

Erkancakir

  • 5 Керемет 7 пікірлер
  • 35 жылдар тәжірибе
  • Түркия, Істанбұл, Liv Hospital Vadistanbul
  • Dr. Erkancakir is a specialist in pediatric chest diseases. He has experience with acute and chronic respiratory problems, respiratory tract infections, and bronchoscopic procedures. His areas of focus include asthma, sleep-related breathing disorders, cystic fibrosis, and tuberculosis.

    He completed his medical degree at Istanbul University. He continued his specialty training at Göztepe Training and Research Hospital and Marmara University. Dr. Erkancakir has worked at leading institutions, such as Bezmialem Vakıf University and Süreyyapaşa Chest Diseases Training and Research Hospital.

    He is an active member of several professional organizations, including the Turkish Thoracic Society and the European Respiratory Society. Dr. Erkancakir has received more than 20 national and international awards for his research and presentations, especially in pediatric pulmonology and cystic fibrosis.

  • Толығырақ оқу
Блуждаушы нервті ынталандыру
22 000 $ - 22 000 $
Химиотерапия
3 000 $ - 3 500 $
Ақпарат

Дәрігер мен клиниканы дұрыс қалай таңдау керек: сарапшылардың ұсыныстары

Дәрігер немесе клиника таңдағанда осы негізгі сәттерді есте сақтаңыз:
Біліктілікті тексеріңіз
ISAPS, JCI және т.б. сияқты ұйымдардан сертификаттардың болуына көз жеткізіңіз.
Процедуралардың табыстылығы туралы біліңіз
Сізге қажет саладағы үлкен тәжірибесі бар дәрігерлерді таңдаңыз.
Науқастардың пікірлерін оқыңыз
Олардың тәжірибесі туралы тікелей білу үшін Bookimed сайтындағы нақты науқастардың пікірлерімен танысыңыз.
Тиімді коммуникация мүмкіндігіне көз жеткізіңіз
Сіздің барушы максималды жайлы өтуі үшін аудармашы қызметтерін ұсынатын клиникаларды таңдаңыз.
Қолжетімді қызметтер туралы сұраңыз
Клиника тұрғын үй және трансфер ұсына ма, сондай-ақ бағаларды біліңіз.
Шетелде клиника таңдау қиын болуы мүмкін. Bookimed командасы 800 мыңнан астам науқасқа көмектесті және Сіздің алаңдаушылықтарыңызды түсінеді. Біз сенімді дәрігерлерді, баға мен сапаның ең жақсы арақатынасы бар нұсқаларды және тіпті күрделі жағдайлар үшін шешімдерді қалай табуды білеміз. Біз осы жолдың әрбір қадамында Сізді қолдауға дайынбыз.
Ян Мациевский
Дәрігер-координаторлар тобының басшысы